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Materials and Methods: From March 2003 to December 2012, 
157 pts (median age 64 years –range 39-84) were enrolled. All 
pts underwent total abdominal hysterectomy and bilateral 
salpingo-oophorectomy with or without pelvic lymph-
adenectomy; patological stage (FIGO 2008) was I in 150 pts 
and II in 7 pts. Tumour grading was G1 in 49 pts, G2 in 98 and 
G3 in 10. All pts underwent high-dose-rate vaginal 
brachytherapy (total dose 21 Gy in three week-fractions), 
delivered with vaginal cylinder, with the reference isodose 
covering the proximal ½ of the vagina. The dose was 
specified at 5 mm distance from the cylinder surface. The 
Kaplan-Meier method estimated the probability of loco-
regional relapse free survival (LRFS), distant metastases-free 
survival (DMFS) and cancer-specific survival (CSS). Univariate 
analysis investigated the effect of age, grading, number of 
excised nodes and pathological stage on loco-regional relapse 
(LRR), metastases, and tumour-related death. Risk factors in 
univariate analysis were included in proportional hazard 
multivariate models. Vaginal toxicity was evaluated with the 
RTOG/EORTC scale and was correlated with the cylinder 
diameter (2.5, 3 or 3.5 cm).  
Results: LRFS occurred in 9/157 (5.8%) pts. Three pts (1.9%) 
developed liver metastases. At median follow-up of 83 
months 144 pts (91.8%) are alive and disease free, 2 pts 
(1.2%) are alive with disease, 7 pts (4.5%) died from disease 
and 4 pts (2.5%) died from other causes. The 3-year 
probability of LRFS, DMFS and CSS was 94.5% (95%CI:89.4-
97.2), 98.7% (95% CI: 94.9-99.7) and 96,5% (95% CI: 91.8-98.5) 
respectively. Median survival was nor reached for any end-
points. At univariate analysis, risk factors for LRR were stage 
pII (HR: 3.638; 95% CI:1.3-9.8; p=0.011) and less than 12 
excised nodes (HR: 7.057; 95% CI:1.6-29.5; p=0.008), while 
Stage pII was risk factor for metastasis (HR: 22.7; 
95%CI:2.392-215.4; p=0.007) and tumour-related death (HR: 
4.043; 95% CI: 1.2-13.2; p=0.021). In multivariate Cox-
regression analysis, stage pII and less than 12 nodes sampled 
were significantly associated with LRR (HR: 3.88; 
95%CI:1.390-10.878; p=0.010 and HR: 6.952; 95%CI: 1.591-
30.385; p=0.010), whereas only stage pII was associated with 
metastasis (HR: 23.1; 95%CI: 2.296-231.485; p=0.008) and 
tumour-related death (HR: 4.324; 95% CI: 1.223-15.290; 
p=0.023). Treatment was well tolerated. No pts developed 
acute or late grade III-IV toxicity. No correlation between the 
diameter of the applicator and the onset of acute (p=0.512) 
and chronic (p=0.433) toxicity was observed .  
Conclusions: Post-operative VBT in pts with early stage 
endometrial cancer is effective in ensuring vaginal control, 
with fewer toxic effects.  
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Purpose/Objective: Current practice on gynecologic 
brachytherapy requires the use of MRI, following the GEC-
ESTRO recommendations (Haie-Meder 2005, Potter 2006). MRI 
exclusively based treatment planning is preferred because 
the resulting accuracy. Catheter reconstruction based only on 
MRI is a challenge (Hellebust 2010). A new template named 
Template Benidorm (TB) has been recently developed 
(Rodriguez 2014). It adapts the currently existing 
manufactured MR compatibles intrauterine tubes, together 
with Titanium needles, resulting fully MRI compatible. In 
titanium needles dummy-marker catheters cannot visualize 
signals inside the tubes, so the reconstruction only can be 
done with the needle itself. An artifact exists at the end of 
the needle and the tip is assumed to be at the middle of the 
signal void. The purpose of this work is to improve the 
titanium needle reconstruction uncertainty for the TB case 
using a simple method based on the free needle lengths. 
Materials and Methods: MRI imaging is performed on a GEMS 
1.5 T. A T2 sequence is used for contouring and a 3D radio-
frequency Spoiled Gradient recalled Echo sequence to 
maximize the titanium needles signal (Petit 2013) 
On the TB, for the tandem case the reconstruction is done 
using the existing MRI dummies (Perez-Calatayud 2009). For 
the needles, the proposed reconstruction method is based on 
the free length obtained outside of the external template 
plate as follow: 
The TB has both non-divergent and divergent needles. The 
proposed procedure consists on the inclusion of three small 
A-vitamin pellets compressed by both applicator plates. The 
pellets plane gives the central plane of the plate’s 
arrangement. Because A-vitamin produces an adequate signal 
on MRI, these pellets can be easily identified on the 
acquisition study, obtaining their coordinates. From these, a 
plane is defined. For each needle, two points are obtained 
and then the straight line defined. From straight line and 
plane equations the intersection is obtained and using the 
free length (knowing the offset distance) the coordinates of 
the needle tip are obtained. Knowing the tip coordinates, 
these can be introduced on the TPS by keyboard. Although 
we use it in our TPS Oncentra (Elekta) the procedure is 
applicable to any TPS. 
Results: This technique has been applied to the last 3 
patients treated with the TB. The method has been 
programmed on a spreadsheet and its application is very 
efficient, avoiding the laborious needle reconstruction and 
their tips uncertainties because the void artifact.The A-
vitamin pellets are easily identified and for each needle just 
two points are required.  
Conclusions: A simple and practical method has been 
developed to optimize the titanium needle reconstruction on 
the Template Benidorm used in gynecological brachytherapy. 
It improves the uncertainty and the efficiency allowing 
exclusively MRI based planning. 
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Purpose/Objective: To analyse the outcome of Carcinoma 
Cervix patients treated with CT based planning for both 
External beam treatment and Brachytherapy, with the 
objective of understanding the benefits afforded by image 
based optimised Brachytherapy. 
Materials and Methods: Data of 60 patients from among 509 
radically treated Cervix cancer patients treated with CT 
based treatment plans, between January 2011 to December 
2012 were analysed for outcome. In view of extreme number 
of patients and limited resources, treating every patient with 
conformal RT is far from reality at our centre. Hence after 
the instillation of CT simulator at our centre, conventional 
pelvic EBRT portals were planned on CT images, making field 
adjustments ensuring target coverage, on the basis of soft 
tissue imaging information. Subsequently on similar lines CT 
imaging was used for Brachytherapy planning and isodose 
shaping to cover the cervix and uterus while keeping the 
normal organ doses within normal limits was attempted. CT 
optimization in Brachytherapy was to reduce OAR doses if 
found excessive with standard planning and Point A dose 
prescription. Subsequently dose volume optimization was 
attempted. But where the central disease was of small 
volume the point A dose was still kept at the standard 
prescription range if the OAR doses were acceptable. 
Results: At a median follow up of 22 months (5-36mo), 9 
patients in the CT planned group documented relapse. 4 
patients had distant relapse and 5 had pelvic recurrence. Of 
the pelvic recurrences one patient recurred outside the 
initial treatment field (lower vaginal) and one patient 
documented progressive disease while on EBRT. The 3 other 
patients with true in-field recurrence had very advanced 
disease at presentation with bladder infiltration on imaging. 
Proper Brachytherapy application was not possible in 2 of 
these patients due to poor anatomy. There were no 
documented grade 2, 3 bladder toxicity. 6 patients had grade 
2 rectal toxicity. During the same period there were 32 
relapses and 16 isolated infield failures among the 258 CT 
planned patients treated with conventional 2D 
Brachytherapy. Also there were 22 grade 2 rectal toxicities in 
the patients treated with 2D brachytherapy. 
Conclusions: CT imaging information could be used for EBRT 
and Brachytherapy planning with excellent clinical outcome 
in a setting with large patient numbers and limited resources. 
Technology adaptation to suit our conditions is important for 
improving outcome of cervix cancer patients in the 
developing world. 
   
PO-1023   
Impact of inhomogeneity correction for vaginal vault 
brachytherapy CT planning 
W. Keough1, M. Zahra2 
1Edinburgh Cancer Centre, Medical Physics, Edinburgh, 
United Kingdom  
2Edinburgh Cancer Centre, Clinical Oncology, Edinburgh, 
United Kingdom  
 
Purpose/Objective: To evaluate the dosimetric impact of 
implementing inhomogeneity corrections for vaginal vault 
brachytherapy and assess for correlations with patient 
related factors. 
Materials and Methods: The plans of 48 consecutive patients 
treated with post-operative HDR vaginal vault brachytherapy 
using a single line source were evaluated. All patients had a 
planning CT scan with the vaginal cylinder in situ. The PTV 
consisted of the cranial 4 cm of vagina to a depth of 5mm, 
and any gas in the bowel was outlined over a standard 
number of CT slices and the volume measured and the 
diameter of the equivalent sphere estimated. The point doses 
for 3 randomly placed points in the PTV were measured and 
compared for a plan assuming a homogeneous tissue density 
equivalent to water (1g/cm3)with another plan using Acuros ™ 
correction for tissue inhomogeneities. The 2-sample T-test 
for unequal variances (t) and the Pearson's correlation 
coefficient (r) with 2-tail significance testing at level of ≤ 
0.05 were used to evaluate the differences and study the 
correlations between the 2 plans and patient related factors 
of: volume of gas in bowel, age, vaginal length and cylinder 
diameter. The differences in dwell times between the 2 plans 
were used to generate 2 subgroups: the 1st quartile and the 
4th quartile. 
Results: For the 48 patients in the study the median age: 67 
yrs(22 - 82 yrs), and post-operative vaginal length: 11cm (8 -
13cm). The cylinder diameters used: 17% had 2.6cm, 19% had 
3cm and 64% had 3.5cm. The median volume of gas: 9.58cm3 
(0.08 – 115.4cm3) and the diameter for the equivalent 
sphere: 2.6cm (0.5 – 6cm). The Acuros correction resulted in 
a median increase in dwell times of 2.35%(2.0 – 3.52%).The 
percentage increase in dwell times correlated with the 
volume of gas (r=0.815; p=0.0000072) and the diameter of 
equivalent sphere (r=0.783;p=0.000037) but not with the 
vaginal length or cylinder diameter. On comparison of the 2 
subgroups there were significant differences in volume of air 
(t=1.76;p=0.0013) and sphere diameter (t=1.72; p=0.00008) 
but not in vaginal length or cylinder diameter. 
Conclusions: The use of inhomogeneity correction for vaginal 
vault brachytherapy will reflect more accurately the 
dosimetry at the time of the scan. It is significantly 
influenced by the volume of gas in the bowel which may not 
be constant throughout a fractionated course of treatment. 
Further studies on reproducibility are required. 
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Purpose/Objective: To analyze the long term results of daily 
high dose-rate brachytherapy (HDRBT) in vaginal-cuff 
relapses (VCR) and toxicity in postoperative endometrial 
carcinoma (EC). 
Materials and Methods: From January 2007 to September 
2011, 153 patients with FIGO Stage 38-IA, 69-IB, 16-II, 13-IIIA, 
2-IIIB, 10-IIIC1 and 5-IIIC2, were treated with HDRBT after 
surgery. Pathology: 136 /153 endometrioid adenocarcinoma 
and 17/153 other types. Radiotherapy: Group 1: 94/153 
